pharmacor roxithromycin
apotex pty ltd - roxithromycin -
clarithyromycin 125/5 mg/ml granules for oral suspension
rowex ltd - clarithromycin - granules for oral suspension - 125/5 mg/ml
clarithyromycin 250/5 mg/ml granules for oral suspension
rowex ltd - clarithromycin - granules for oral suspension - 250/5 mg/ml
ees erythromycin 200mg/5ml (as ethyl succinate) granules for oral liquid bottle
amdipharm mercury australia pty ltd - erythromycin ethyl succinate -
ees erythromycin (as ethyl succinate) 400mg/5ml granules for oral liquid bottle
amdipharm mercury australia pty ltd - erythromycin ethyl succinate -
roxy tablet 150mg
imeks pharma sdn. bhd. - roxithromycin -
roxithromycin - hexal 150 mg
hexal -
clarithyromycin granules for oral suspension 125/5 mg/ml
rowex ltd - clarithromycin - granules for oral suspension - 125/5 mg/ml
clarithyromycin granules for oral suspension 250/5 mg/ml
rowex ltd - clarithromycin - granules for oral suspension - 250/5 mg/ml
biaxsig 300mg blister pack
sanofi-aventis australia pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: purified talc; colloidal anhydrous silica; hypromellose; titanium dioxide; magnesium stearate; povidone; hyprolose; glucose; maize starch; propylene glycol; poloxamer - for the treatment of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms in; acute pharyngitis, tonsillitis, and sinusitis. acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia (including atypical pneumonia). skin and soft tissue infections and non-gonococcal urethritis